US 11358932
N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
granted A61PA61P1/04A61P11/06
Quick answer
US patent 11358932 (N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/04, A61P11/06, A61P13/12, A61P19/02